Press Releases
Jaguar Gene Therapy Announces Samsung and JDRF T1D Fund as New Investors
MEDIA FOCUS
Jaguar Gene Therapy Announces Samsung and JDRF T1D Fund as New Investors
Samsung Life Science Fund, established by Samsung Biologics and Samsung C&T Corporation last year, has announced that it will invest in US-based Jaguar Gene Therapy, a leading biotech company that develops breakthrough gene therapy treatments for people suffering from diabetes and other severe genetic diseases.
MEDIA FOCUS
Jaguar Gene Therapy Announces Samsung and JDRF T1D Fund as New Investors
Samsung Life Science Fund, established by Samsung Biologics and Samsung C&T Corporation last year, has announced that it will invest in US-based Jaguar Gene Therapy, a leading biotech company that develops breakthrough gene therapy treatments for people suffering from diabetes and other severe genetic diseases.